More affordable prices, with more flexible dosing options and greater diversity of form factors, means more people can find an FDA-approved treatment that best fits their budget, goals, and daily life
It also requires you to have commercial insurance
The prices are much better than elsewhere, and Im definitely happy with my results so far
Retatrutide is part of a new class of obesity medications sometimes nicknamed triple agonists. While popular drugs like Ozempic target one hormone pathway, GLP-1, and Zepbound activates two GLP-1 and GIP retatrutide targets three hormone receptors at once: GLP-1, GIP, and glucagon
Patients should not attempt to source or self-administer this medication outside of a regulated clinical setting